Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Other

EMERGENT BIOSOLUTIONS INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-02-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common stock, $0.001 par value per share · EBS · NYSE.
  • 2025-03-04: Form 10-K; Item Stock registered under Section 12(b); As filed Common stock, $0.001 par value per share · EBS · NYSE.
  • 2025-03-04: Form 10-K; Item Well-known seasoned issuer; As filed No.
  • 2024-03-08: Form 10-K; Item Stock registered under Section 12(b); As filed Common stock, $0.001 par value per share · EBS · NYSE.
FiledFormItemAs filed
2026-02-2710-KStock registered under Section 12(b)Common stock, $0.001 par value per share · EBS · NYSE
2025-03-0410-KStock registered under Section 12(b)Common stock, $0.001 par value per share · EBS · NYSE
2025-03-0410-KWell-known seasoned issuerNo
2024-03-0810-KStock registered under Section 12(b)Common stock, $0.001 par value per share · EBS · NYSE
2024-03-0810-KWell-known seasoned issuerNo
2023-12-1110-QStock registered under Section 12(b)Common Stock, par Value $0.001 per share · EBS · NYSE
2023-12-1110-K/AStock registered under Section 12(b)Common stock, $0.001 par value per share · EBS · NYSE
2023-12-1110-K/ACurrent in its reportingNo
2023-08-0910-QStock registered under Section 12(b)Common Stock, par Value $0.001 per share · EBS · NYSE
2023-05-1010-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2023-03-0110-KStock registered under Section 12(b)Common stock, $0.001 par value per share · EBS · NYSE
2022-11-0910-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2022-08-0210-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2022-04-2910-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2022-02-2510-KStock registered under Section 12(b)Common stock, $0.001 par value per share · EBS · NYSE
2021-11-0510-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2021-07-3010-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2021-04-3010-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2021-02-1910-KStock registered under Section 12(b)Common stock, $0.001 par value per share · EBS · NYSE
2020-11-0610-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2020-07-3110-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2020-05-0110-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2020-02-2510-KStock registered under Section 12(b)Common stock, $0.001 par value per share · EBS · NYSE
2019-11-0710-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2019-08-0210-QStock registered under Section 12(b)Common Stock, Par Value $0.001 per share · EBS · NYSE
2014-11-1010-QCurrent in its reportingNo
2014-08-0810-QCurrent in its reportingNo
2014-05-1210-QCurrent in its reportingNo
2014-03-1010-KWell-known seasoned issuerNo
2013-11-0810-QCurrent in its reportingNo
2013-08-0610-QCurrent in its reportingNo
2012-05-0410-QCurrent in its reportingNo
2012-03-0910-KCurrent in its reportingNo
2011-11-0410-QCurrent in its reportingNo
2011-11-0410-QWell-known seasoned issuerNo
2011-08-0510-QWell-known seasoned issuerNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45